论文部分内容阅读
本刊讯11月16日,《自然》杂志的报道确认了全球首个CRISPR技术的人体应用已在中国启动的消息。CRISPR基因编辑技术是近年生物技术领域的热点。《自然》杂志的报道则证实了华西医院的卢铀教授团队已开启全球首个CRISPR技术的人体应用。这项临床试验的招募对象是患有非小细胞肺癌,且癌症已经发生扩散,化疗、放疗及其他治疗手段均已无效的患者。按计划,卢铀教授的团队从招募的患者体内分
The Journal of November 16, “Nature” magazine confirmed that the world’s first human CRISPR technology applications have been launched in China news. CRISPR gene editing technology in recent years, the field of biotechnology hot spots. The coverage of Nature magazine confirms that Lu Yu-uu’s team at West China Hospital has launched the world’s first human application of CRISPR technology. Patients enrolled in this clinical trial were those with non-small cell lung cancer that had already had cancer spread, chemotherapy, radiotherapy, and other treatments ineffective. According to the plan, Professor Lu Yu team from recruiting patients in vivo points